University of Ioannina
Εκτίμηση της ικανότητας κλινικών και εργαστηριακών παραμέτρων να προβλέπουν την εμφάνιση σακχαρώδη διαβήτη τύπου 2 σε ασθενείς με σακχαρώδη διαβήτη κύησης
Abstract
dc:descriptionIntroduction: Gestational diabetes mellitus (GDM), the metabolic disease that occurs in pregnant women and increases the risk for the development of diabetes remains incompletely understood. Metabolomics provides essential input into the etiology and pathogenesis of disease states and contribute to the discovery of biomarkers for an early and accurate detection. Nuclear magnetic resonance (NMR) spectroscopy is a key platform for the measurement of the metabolome has been previously used to define metabolic signatures associated with in intact serum/plasma with limited ability to identify metabolites and elucidate the corresponding metabolic pathways. Aim: In the present study, we used NMR-based metabolic analysis of the macromolecules free-serum of GDM women to increase the number of quantified metabolites for a more accurate characterization of the altered metabolic pathways leading to GDM and to examine their similarity with those associated with DM2. Methods: Sixty-two Caucasian women with GDM were included. Seventy-seven healthy Caucasian pregnant women with normal glucose tolerance matched, for week of gestation, BMI, blood pressure and serum lipid levels comprised the control group. 1H NMR spectra of the serum samples were acquired on a 11.7 T Bruker Avance DRX NMR spectrometer using a standard 1D Nuclear Overhauser Enhancement Spectroscopy (NOESY) presaturation pulse sequence. Chenomx NMR Suite software was used for the identification and quantification of the metabolites and Metaboanalyst v.4.0 for multivariate statistical analysis. Results: Fifty-five metabolites were identified in the 1H NMR spectra of control and GDM groups 25 of which were significantly altered by the presence of gestational diabetes. Compared with normal pregnancy, women who were diagnosed with GDM showed significantly elevated levels of the ketone bodies 3-hydroxybutyrate and acetoacetate, of the organic acid 2-hydroxybutyrate and the metabolic intermediates of BCAAs, 3-hydroxyisobutyrate and 3-hydroxyisovalerate. Significantly lower in GDM patients were the levels of the metabolites involved in one-carbon metabolism (methionine, glycine, serine, choline, sarcosine), in energy production (carnitine and pyruvate), in purine metabolism (hypoxanthine), the amino acids arginine, asparagine, aspartate, histidine, glutamate, phenylalanine and tryptophan, the catabolic product of BCAAs 3-methyl-2-oxovalerate, the intermediate of urea cycle ornithine as well as 2-aminobutyrate and the osmolytes taurine and trimethylamine N-oxide. Conclusion: Metabolic pathways mainly affected in GDM are beta-oxidation, ketone bodies metabolism, one-carbon metabolism, arginine and ornithine metabolism in a manner similar to that in DM2, whereas BCAAs catabolism, aromatic amino acids metabolism and gut microbiota were affected, but in a different way than in DM2.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spanou, Loukia
- Σπανού, Λουκία
Subjects
dc:subject × 18- Σακχαρώδης διαβήτης κύησης
- Μεταβολομική
- Φσματοσκοπία NMR
- Gestational diabetes mellitus (GDM)
- Metabolomics
- Nuclear magnetic resonance (NMR) spectroscopy
- Type 2 diabetes
- Pathway analysis
- Personalized medicine
- Pregnancy
- Biomarkers
- Macromolecules free-serum
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53953